By otakuyassine3@gmail.com 
Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) has been given a consensus recommendation of “Hold” by the seven brokerages that are covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $30.14.
OPCH has been the topic of several analyst reports. Truist Financial dropped their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. UBS Group began coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, Barrington Research reduced their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st.
Get Our Latest Research Report on Option Care Health
Option Care Health Stock Performance
Shares of OPCH stock opened at $22.66 on Tuesday. The company’s fifty day moving average price is $24.02 and its two-hundred day moving average price is $28.02. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market capitalization of $3.86 billion, a P/E ratio of 19.04, a P/E/G ratio of 2.43 and a beta of 1.33. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63.
Insiders Place Their Bets
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The stock was bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.64% of the stock is owned by insiders.
Institutional Investors Weigh In On Option Care Health
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. UMB Bank n.a. increased its stake in Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares during the period. International Assets Investment Management LLC raised its holdings in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares in the last quarter. Finally, Quarry LP lifted its position in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after purchasing an additional 2,628 shares during the period. 98.05% of the stock is currently owned by institutional investors.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
Receive News & Ratings for Option Care Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Option Care Health and related companies with MarketBeat.com’s FREE daily email newsletter.